SCHEMBL13545871

SCHEMBL13545871

C[C@H](NC(=O)c1[nH]nc2c1CCCC2)c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
LMNA P02545 3/20 0.56
MAPK1 P28482 1/20 0.56
NPC1 O15118 2/20 0.48
RAB9A P51151 1/20 0.48
BDKRB1 P46663 1/20 0.47
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
MAPT P10636 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
KDM4E B2RXH2 6/20 0.44
NTSR1 P30989 1/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALPL P05186 1/20 0.43
ALPI P09923 1/20 0.43
ALPG P10696 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6919429 0.84 ALDH1A1 (0.42) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL14140710 0.72 ALDH1A1 (0.98) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL13545765 0.72 ALDH1A1 (0.98) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL13545834 0.72 ALDH1A1 (0.98) ALDH1A1LMNAMAPK1NPC1RAB9A
SCHEMBL1779826 0.69 ROCK2 (0.51) ALDH1A1LMNAMAPK1NPC1MEN1
SCHEMBL1781134 0.69 ROCK2 (0.51) ALDH1A1LMNAMAPK1NPC1MEN1
SCHEMBL10268652 0.69 MAPT (0.70) ALDH1A1MAPK1MEN1KMT2AMAPT
SCHEMBL13597940 0.68 KMT2A (0.61) ALDH1A1LMNANPC1RAB9AMEN1
SCHEMBL17149686 0.67 MEN1 (0.51) ALDH1A1LMNAMAPK1MEN1KMT2A
SCHEMBL17149705 0.67 MEN1 (0.51) ALDH1A1LMNAMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 US disclosed
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2010-01-28 US disclosed
WO-2008080455-A1 TETRAHYDROBENZOISOXAZOLE - AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN MERCK PATENT GMBH (DE) 2008-07-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022530-A1 TETRAHYDROBENZOISOXAZOLE AND TETRAHYDROINDAZOLE DERIVATIVES AS MODULATORS OF THE MITOTIC MOTOR PROTEIN CCNB3, TUBB3, CCNB1 ALDH1A1 2977/4885LMNA 1875/4885MAPK1 2172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.